---
title: "US FDA grants de novo approval for AI-based HCM detection algorithm"
date: "2023-08-15T10:01:41.000Z"
publishedDate: "15 août 2023"
summary: "Viz.ai has received a de novo approval by the US Food and Drug Administration (FDA) for its Viz HCM module, a hypertrophic cardiomyopathy (HCM) artificial intelligence (AI) detection algorithm. The deployment of the algorithm is financially supported by a multi-year agreement with Bristol Myers Squibb announced in March."
importance: ""
sourceUrl: "https://cardiovascularnews.com/us-fda-grants-de-novo-approval-for-ai-based-hcm-detection-algorithm/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2023-08-15-us-fda-grants-de-novo-approval-for-ai-based-hcm-detection-algorithm"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/08/AdobeStock_178585512-remote-care.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/us-fda-grants-de-novo-approval-for-ai-based-hcm-detection-algorithm/"
---

![US FDA grants de novo approval for AI-based HCM detection algorithm](https://cardiovascularnews.com/wp-content/uploads/sites/14/2023/08/AdobeStock_178585512-remote-care.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/us-fda-grants-de-novo-approval-for-ai-based-hcm-detection-algorithm/*

## L’essentiel

Viz.ai has received a de novo approval by the US Food and Drug Administration (FDA) for its Viz HCM module, a hypertrophic cardiomyopathy (HCM) artificial intelligence (AI) detection algorithm. The deployment of the algorithm is financially supported by a multi-year agreement with Bristol Myers Squibb announced in March.

## Lien source

https://cardiovascularnews.com/us-fda-grants-de-novo-approval-for-ai-based-hcm-detection-algorithm/
